Sierra Oncology, Inc. Gains 46.23%
Tue, Jan 25, 2022 at 05:30 PM
Sierra Oncology, Inc. (SRRA:NASDAQ) soared at $22.68, a gain of 46.2%. On Mon, Jan 24, 2022, SRRA:NASDAQ hit a New 2-Week Low of $15.51. The stock got featured on our News Catalysts scanner on Tue, Jan 25, 2022 at 04:36 PM in the 'PUBLIC OFFERING' category. From Mon, Jan 10, 2022, the stock recorded 33.33% Up Days and 30.00% Green Days
About Sierra Oncology, Inc. (SRRA:NASDAQ)
Sierra Oncology Inc is a clinical-stage drug development company engaged in next generation DNA Damage Response (DDR) therapeutics for the treatment of patients with cancer.
Top 10 Gainers:
- Capitalworks Emerging Markets Acquisition Corp (CMCA:NASDAQ), 100%
- Sierra Oncology, Inc. (SRRA:NASDAQ), 46.23%
- Aptorum Group Limited (APM:NASDAQ), 38.89%
- Exela Technologies, Inc. (XELA:NASDAQ), 32.95%
- Vistas Media Acquisition Company Inc. (VMAC:NASDAQ), 27.29%
- Aditxt Inc. (ADTX:NASDAQ), 25.66%
- Mind Medicine (MindMed) Inc. (MNMD:NASDAQ), 25.48%
- SmileDirectClub, Inc. (SDC:NASDAQ), 24.62%
- ClearOne, Inc. (CLRO:NASDAQ), 23.46%
- Bally's Corporation (BALY:NYSE), 22.65%